Lymphomas
- 28 February 1998
- journal article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 27 (2) , 157-160
- https://doi.org/10.1016/s1040-8428(97)10028-2
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.Journal of Clinical Oncology, 1998
- Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.Journal of Clinical Oncology, 1997
- Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimenAnnals of Oncology, 1996
- The role of Epstein—Barr virus in the pathogenesis of Hodgkin's diseaseAnnals of Oncology, 1996
- The management of Hodgkin's disease: Half a century of changeAnnals of Oncology, 1996
- Reducing chemotherapy-associated toxicity in elderly cancer patientsCancer Treatment Reviews, 1996
- Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyAnnals of Oncology, 1994
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- IdarubicinDrugs, 1991
- Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing AgeJournal of the American Geriatrics Society, 1984